Universe Pharmaceuticals (UPC) Raw Materials (2021 - 2025)

Universe Pharmaceuticals has disclosed Raw Materials across 5 years of filings, most recently posting $2.5 billion for Q3 2025.

• Raw Materials for Q3 2025 came in at $2.5 billion, up 245.78% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.5 billion (up 245.78% YoY), and the FY2025 annual result was $2.5 billion, up 245.78% from the prior year.
• Raw Materials came in at $2.5 billion for Q3 2025 at Universe Pharmaceuticals, up from $720.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.5 billion in Q3 2025 to a low of $16701.0 in Q3 2022.
• The 5-year median for Raw Materials is $2.7 million (2021), against an average of $642.6 million.
• Across the five-year window, Raw Materials slumped 99.39% in 2022 and soared 113221.79% in 2024, its largest moves.
• Universe Pharmaceuticals' Raw Materials stood at $2.7 million in 2021, then plunged by 99.39% to $16701.0 in 2022, then soared by 3704.53% to $635395.0 in 2023, then jumped by 113221.79% to $720.0 million in 2024, then soared by 245.78% to $2.5 billion in 2025.
• The last three Raw Materials figures came in at $2.5 billion (Q3 2025), $720.0 million (Q3 2024), and $635395.0 (Q3 2023), per Business Quant data.